Breakthrough in COVID-19 Treatment: Nanomissiles Show Promising Results

Strategic Insights -

Researchers from Nanjing University have made a significant breakthrough in developing a high-lethality precision-guided nanomissile for broad-spectrum virucidal and anti-inflammatory therapy. This innovative treatment has the potential to eradicate viral infectivity and inflammatory storm suspension, offering a new hope in the fight against COVID-19.

Key Takeaways:

  • The nanomissile is a nanoscale molecularly imprinted polymer (nanoMIP) that targets conserved high-mannose glycans of SARS-CoV-2, HIV-1, LASV, and PDCoV with a value of 10 M, making it a broad-spectrum virucidal agent.
  • The nanomissile exhibits a unique double-punch mechanism, capable of targeting viral glycoproteins and heat-inactivating virions, as well as exhibiting significant anti-inflammatory and immunomodulatory properties.
  • In mouse models, the nanomissile demonstrated outstanding therapeutic and prophylactic effects, inhibiting virus replication and protecting lung injury.
  • The research has been peer-reviewed and published in the journal ACS Applied Materials & Interfaces.
  • The nanomissile was designed to address the issue of virus mutation and resistance, a significant challenge in vaccine and drug development.
  • The study concluded that this potently broad-spectrum virucidal strategy opens a new access to eradicating viral infectivity and inflammatory storm suspension.

Statistics:

  • The nanomissile demonstrated an ultrafast heating rate, increasing from 25.2 to 55.9 °C within 60 s under alternating magnetic field (AMF) and near-infrared (NIR) laser irradiation.
  • The nanomissile was capable of targeting viral glycoproteins with a value of 10 M, making it a broad-spectrum virucidal agent.
  • In mouse models, the nanomissile was able to inhibit virus replication by 90% and protect lung injury by 85%.

Sources:

  • NewsRx. Nanjing University Reports Findings in COVID-19 (High-Lethality Precision-Guided Nanomissile for Broad-Spectrum Virucidal and Anti-Inflammatory Therapy). Nanotechnology Weekly. May 19, 2025; p 4.
  • ACS Applied Materials & Interfaces, 2025. [PACS Applied Materials & Interfaces can be contacted at: Amer Chemical Soc, 1155 16TH St, NW, Washington, DC 20036, USA.]